Summary: U.S. stock futures mixed, Dow futures down 0.1%. AirSculpt Technologies shares fell 13.4% a

BOSTON, Aug. 06, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on im

BOSTON, Aug. 03, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on im

BOSTON, July 07, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on im

BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on im

BOSTON, June 01, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on im

BOSTON, May 27, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on imp

X4 Pharmaceuticals (XFOR) witnesses a hammer chart pattern, indicating support found by the stock af

X4 Pharmaceuticals (XFOR) might move higher on growing optimism about its earnings prospects, which

X4 Pharmaceuticals (XFOR) came out with a quarterly loss of $0.16 per share versus the Zacks Consens

- Global 4WARD Phase 3 Chronic Neutropenia Trial On Track to Complete Enrollment by the end of Q3 20

- European Commercialization will be Led by X4 Pharmaceuticals' Partner, Norgine -  - Global, Pivota

BOSTON, April 01, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on i

X4 Pharmaceuticals (XFOR) came out with a quarterly loss of $0.22 per share versus the Zacks Consens

- Global 4WARD Phase 3 Chronic Neutropenia Trial On Track to Complete Enrollment in Q3 2026 - - Posi

Analyst sentiment across three small-cap biotechs has turned notably positive, with fresh coverage i

BOSTON, March 04, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on i

X4 Pharmaceuticals (XFOR) is rated BUY, driven by a funded Phase 3 trial, current product pipeline,

BOSTON, March 02, 2026 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on i

- Potential First and Only Therapy in the EU for Ultra-Rare Immune Disorder - BOSTON, Feb. 27, 2026

X4 Pharmaceuticals, Inc. (XFOR) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2

Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a pro

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterl

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and

  During Friday's trading, 293 companies set new 52-week lows.

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin

  Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for

  On Thursday, 588 stocks hit new 52-week lows.

  During Monday's session, 77 companies made new 52-week lows.

  On Friday, 1043 companies hit new 52-week lows.

  During Wednesday's trading, 435 companies set new 52-week lows.

  During Thursday, 849 stocks hit new 52-week lows.

  During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week

Gainers  

  Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e

    On Friday morning, 155 companies achieved new lows for the year.

  Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly e